Disclaimer
Acknowledgements
Introduction
About the Author
Index of Key Performance Indicators
PART I: THE GAP IN OBESITY MEDICINE
Chapter 1: Miracles and Misconceptions
Why Diets Fail
A New Class of Medicine
Lifelong Treatment
The System Failure
Endnotes
Chapter 2: The Monetization of Obesity Medicine
The Market Gap
A Warning from Another Drug Class
What These Medications Actually Cost
Why 15 Percent Is Conservative, Not Aspirational
Why Manufacturers May Accept Lower Revenue
The Compounded GLP-1 Market
Endnotes
Chapter 3: Why You Are Reading, and I Am Writing This Book
Where You Are Sitting
What This Book Is For
Why This Market Is Counterintuitive
What Clinical Trials Actually Provide
The Retention Problem
Two Categories of Solvable Problems
How Value Gets Captured
What This Book Offers
The Invitation
Endnotes
PART II: KEEPING YOUR CUSTOMERS: LESSONS FROM THE OUTSIDE
Chapter 4: The Apple Pricing Lesson
Where Apple Actually Makes Money
The Actual Cost of Making These Medications
The Availability of Medications in Oral Form
Global Pricing on the Horizon
The Best Buy Alternative
The Customer Acquisition Cost Crisis
Wayne’s Calculation
Two Types of Gaps
What about the App Store and the Geek Squad?
Endnotes
Chapter 5: The Ticketmaster Trap
The Regulatory Squeeze
The Prescription Economics Problem
The Primary Care Myth
The Cash-Pay Bypass
Sarah’s Brand-Trust Problem
The Canadian Crystal Ball
Bridge Behavior: Direct-to-Consumer Pricing
The Escape Route
Endnotes
Chapter 6: Peloton Was Not Selling Bikes
High Retention, Wrong Metric
The $50 Billion Manufacturing Bet
How Peloton Saved Itself
What Made the Peloton Subscription Stick
WeightWatchers Was Watching
What Drives Discontinuation?
What Belonging Looks Like in Practice
Endnotes
Chapter 7: Fitbit: Data Without Interpretation
Data Without a Story
The Fitbit Bet
The Hardware Choice
What Interpretation Looks Like
What the Livongo Outcome Shows
Endnotes
Chapter 8: Zara Is Built to Listen
How Information Moves
Responding to Patient Needs
The Zara Culture
Zara’s Listen-Respond Loop
Endnotes
PART III: THE CANOPY: BUILDING THE INFRASTRUCTURE FOR PATIENT SUCCESS
Chapter 9: The Two Last Miles
The Monocrop
The Canopy Framework
Retention Does Not Matter
The Canopy Framework Key Performance Indicators
Why Empowerment Lives in the Whole Canopy
Two Example KPIs
What Follows
Endnotes
Chapter 10: Cost in the Canopy
Product-Price Fit
The Four Cost Component KPIs
The Flywheel of Success
KPI Games
Complexity and the Canopy
Endnotes
Chapter 11: Coverage in the Canopy
How Coverage Works
Coverage Is Access
Creative Coverage
The Long Game for Coverage
From Coverage to Care
Endnotes
Chapter 12: Care in the Canopy
The Monocroppers
Good Care Handles Complexity
Care Plans Live
Care Transforms
Care Requires Learning
Endnotes
Chapter 13: Curriculum in the Canopy
How We Learn
The Status Quo Problem
The Curriculum Lives On
The Restriction Era is Over
Endnotes
Chapter 14: Coach in the Canopy
Bridging the Know-Do Gap
The Patient’s Choice
The Patient Who Goes Quiet
Wayne’s Coach
Profile: nymble.health—Closing the Know-Do Gap
Endnotes
Chapter 15: Community in the Canopy
Bias Busting
Helping Helps Helpers, Too
More Than a Bulletin Board
The Peer Ownership Pivot
Livy’s Peloton
Sarah in the Community
Endnotes
Chapter 16: Connection in the Canopy
Listening between Visits
What Would the Monocrop Do?
Listening, Interpretation, and Sense-Making
Connection KPIs
Big Learning Comes from Big Listening
Sarah, Connected
RxFood—Patient-Centered Nutrition Support
Endnotes
Chapter 17: Transformation in the Canopy
The Canopy, Revisited
Whole Canopy Patient Behavior KPIs
Whole Canopy Program Stewardship KPIs
What about Weight?
An Invitation to the Canopy
Endnotes
Index